January 20, 2021
UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
September 7, 2021
Nanoengineers at the University of California San Diego have developed COVID-19 vaccine candidates that can take the heat. Their key ingredients? Viruses from plants or bacteria.
April 22, 2022
Urban Electric Power installed rechargeable alkaline battery technology at the San Diego Supercomputer Center, replacing 20,000 pounds of toxic lead-acid batteries with a safer, environmentally friendly and cost-effective alternative, and more than doubling the available battery backup electricity.
March 21, 2023
UC San Diego researchers find stem cells use a surprising system for discarding misfolded proteins. This unique pathway could be the key to maintaining long-term health and preventing age-related blood and immune disorders.
December 7, 2023
ChatGPT and Large Language Models are viewed by many as a threat to the field of computer science education because they’re able to produce code on command. But the retooled, foundational course, “Introduction to Programming and Computational Problem Solving 1” relies on LLMs.
April 7, 2022
…million from the National Science Foundation to build a world-class research platform with the objective to decarbonize the electric grid, protect it from cyber security attacks and make it more resilient. Our campus has become San Diego County’s largest multipurpose hub of EV charging plazas serving more than 5,500 unique…
August 10, 2022
A UC San Diego-led program that monitors wastewater for the presence of SARS-CoV-2 and which has effectively predicted subsequent surges in COVID-19 cases in San Diego has been expanded to detect the presence of monkeypox.
January 18, 2022
The University of California San Diego’s Holocaust Living History Workshop (HLHW) 2021-2022 series continues with five profound events that underscore this year’s theme, “Beyond the Great Silence: The Holocaust in Art, Memory, and Life.”
August 26, 2016
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified RNA-based biomarkers that distinguish between normal, aging hematopoietic stem cells and leukemia stem cells associated with secondary acute myeloid leukemia (sAML), a particularly problematic disease that typically afflicts older patients who have often already…
September 10, 2012
Structural and mechanical engineers at the University of California, San Diego, are working together to create blood flow simulations that could lead to improvements in the design of a cardiac pump for children born with heart defects. They hope that the design changes will improve young patients’ outcomes.
